Nolvadex 20mg – Tamoxifen Citrate for Breast Cancer

Name: Nolvadex 20mg - Tamoxifen Citrate for Breast Cancer
SKU: wc-130
Availability: InStock

$70.00

Astrazeneca’s Nolvadex 20mg, containing Tamoxifen Citrate, treats and prevents certain breast cancers, outperforming some anabolic steroids in specific medical applications, and is distinct from peptide china products.

SKU: wc-130 Category: Anabolic Steroids

Description
Reviews (0)

Nolvadex 20mg, a selective estrogen receptor modulator (SERM), has been fundamental in oncology for decades, treating and preventing breast cancer by blocking estrogen’s effects in breast tissue.

Primary medical indications include adjuvant treatment, metastatic cancer treatment, risk reduction, and ductal carcinoma in situ treatment.

Adjuvant treatment for early-stage, estrogen-receptor-positive breast cancer
Metastatic cancer treatment for advanced hormone-receptor-positive breast cancer
Risk reduction for women at high risk of developing breast cancer
Treatment for ductal carcinoma in situ after surgery and radiation

Tamoxifen works by competitively binding to estrogen receptors, blocking natural estrogen and reducing cancer cell growth, differing from anabolic steroids and peptide products.